The Directorate General of Drug Administration (DGDA) on Tuesday approved Johnson & Johnson's Covid-19 vaccine for emergency use in the country.
In a press release, the DGDA said that people aged 18 or above can be inoculated with the J&J vaccine doses, reports UNB.
This is the sixth Covid-19 vaccine to get DGDA nod for emergency use, but the first single-dose jab approved in the country.
The other approved vaccines are: Covishield produced by Serum Institute of India, Sputnik V of Generium Joint Stock Company of Russia, Sinopharm from Beijing Institute of Biological Products Co. Ltd of China, Pfizer vaccine manufactured by Pfizer Manufacturing Belgium NV, and Coronavac produced by Sinovac Life Sciences Ltd of China.
The J&J vaccine, developed by Belgian drug manufacturer Janssen-Cilag International NV, received approval of the World Health Organization on 12 March and of the European Medicines Agency (EMA) on 11 March.
Besides, other regulators like the World Health Organization, the Food and Drug Administration of the United States of America and Health Canada also approved this vaccine for emergency use.
